Abstract: Disclosed are a parking operation control apparatus and a control method thereof. The apparatus includes a first sensing unit to sense current wheel speed of an automobile in a parking release mode or a current front-wheel speed of the automobile in a parking operation mode, a first controller to receive the current wheel speed and output the same and to store a reference wheel-speed range, a second sensing unit to sense the current wheel speed from the first controller, a first judgment unit to judge whether the current wheel speed deviates from the reference wheel-speed range, or whether the current wheel speed sensed by the second sensing unit is not output, and a regulation unit to regulate the current wheel speed to conform to the reference wheel-speed range when the first judgment unit judges that the current wheel speed deviates from the reference wheel-speed range or is not output.

Abstract: Disclosed are a parking operation control apparatus and a control method thereof. The apparatus includes a first sensing unit to sense current wheel speed of an automobile in a parking release mode or a current front-wheel speed of the automobile in a parking operation mode, a first controller to receive the current wheel speed and output the same and to store a reference wheel-speed range, a second sensing unit to sense the current wheel speed from the first controller, a first judgment unit to judge whether the current wheel speed deviates from the reference wheel-speed range, or whether the current wheel speed sensed by the second sensing unit is not output, and a regulation unit to regulate the current wheel speed to conform to the reference wheel-speed range when the first judgment unit judges that the current wheel speed deviates from the reference wheel-speed range or is not output.

Abstract: An apparatus and method for manufacturing a steel tube are provided. The apparatus includes: a tube-forming device for forming a steel plate into a steel tube; a heat treatment device connected in-line to the tube-forming device to heat the steel tube to a high temperature; a pre-treatment device for annealing the steel tube and providing a reduction atmosphere; and a plating device including a pot for storing a SeAHLume alloy composed of aluminum and zinc in a molten state, a level block selectively inserted into the molten alloy to adjust a level of the molten alloy, and a plating part into which the molten alloy flows in response to insertion of the level block and through which the steel tube passes substantially vertically. Therefore, it is possible to manufacture a steel tube having a plated surface to improve its corrosion-resistance.

Abstract: A post-editing apparatus for correcting translation errors, includes: a translation error search unit for estimating translation errors using an error-specific language model suitable for a type of error desired to be estimated from translation result obtained using a translation system, and determining an order of correction of the translation errors; and a corrected word candidate generator for sequentially generating error-corrected word candidates for respective estimated translation errors on a basis of analysis of an original text of the translation system. The post-editing apparatus further includes a corrected word selector for selecting a final corrected word from among the error-corrected word candidates by using the error-specific language model suitable for the type of error desired to be corrected, and incorporating the final corrected word in the translation result, thus correcting the translation errors.

Abstract: The present invention relates to novel 1,2- or 1,3-diamine and amide compounds and pharmaceutically useful salts thereof and methods for treating central nervous system diseases. The present 1,2- or 1,3-diamine and amide compounds have high binding affinity to the sigma receptor.

Abstract: Provided herein are racemic or enantiomerically enriched benzoyl piperidine compounds and pharmaceutically useful salts thereof, pharmaceutical compositions comprising an effective amount of racemic or enantiomerically enriched benzoyl piperidine compounds to treat central nervous system diseases and methods of treating central nervous system diseases in a mammal, in particular psychoses and cognition disorders.

Abstract: Provided herein are racemic or enantiomerically enriched benzoyl piperidine compounds and pharmaceutically useful salts thereof, pharmaceutical compositions comprising an effective amount of racemic or enantiomerically enriched benzoyl piperidine compounds to treat central nervous system diseases and methods of treating central nervous system diseases in a mammal, in particular psychoses and cognition disorders.

Abstract: The present invention relates to novel 1,2- or 1,3-diamine and amide compounds and pharmaceutically useful salts thereof and methods for treating central nervous system diseases. The present 1,2- or 1,3-diamine and amide compounds have high binding affinity to the sigma receptor.

Abstract: The invention relates to a gas distribution apparatus of semiconductor equipment in which parts are assembled in a simple way in a chamber to thereby improve job efficiency in assembling and disassembling operations and prevent gas leakage outside. The apparatus assembled to supply gas into a chamber for a plasma etching process comprises: a body having a plurality of gas inducing inlets on a downward grooved side of its plate; and an injection plate screwed with the bottom surface of the body, the injection plate having small and large diameters of ring-shaped grooves on its upper surface to connect the gas inducing inlets, the grooves having injection holes formed at a predetermined interval for downward penetration, so as to completely prevent gas leakage outside.

Abstract: O-Carbamoyl-phenylalaninol having substituent at benzene ring, represented by the general formula I, and pharmaceutically useful salts thereof, which are useful for the prophylaxis and treatment of CNS disorder including depression and anxiety, are disclosed: ##STR1## wherein R is lower alkyl containing 1 to 8 carbon atoms, halogen such as F, Cl and I, alkoxy containing 1 to 3 carbon atoms, thioalkoxy containing 1 to 3 carbon atoms, nitro, hydroxy, or trifluorocarbon, and x is an integer of 1 to 3, with a proviso that R is the same or different when x is 2 or 3.

Abstract: The present invention relates to O-thiocarbamoyl-aminoalkanol compound represented by the following structural formula (VI), (VIII) and (IX) which are a racemic or enantiomerically enriched and pharmaceulically acceptable salts thereof to treat diseases of the central nervous system: ##STR1## wherein Ar is a phenyl group as described as follows: ##STR2## wherein R is a member selected from the group consisting of hydrogen, lower alkyl of 1 to 8 carbon atoms, halogen selected from F, Cl, Br, and I, alkoxy containing 1 to 3 carbon atoms, thioalkoxy containing 1 to 3 carbon atoms, nitro, hydroxy, or taifluorocarbon, and x is an integer from 1 to 3, with the proviso that R is the same or different when x is 2 or 3. R.sub.1 and R.sub.2 may be the same or different from each other and are independently selected from the group consisting of hydrogen, lower alkyl of 1 to 8 carbon atoms, aryl, 3 to 7-membered aliphatic cyclic compounds and R.sub.1 and R.sub.

Abstract: The present invention relates to a racemic or enantiomerically enriched O-carbamoyl-phenylalaninol compound represented by the following structural formula V and pharmaceutically acceptable salts thereof to treat diseases of the central nervous system: ##STR1## wherein Ph is a phenyl group as described as follows: ##STR2## wherein R is a member selected from the group consisting of hydrogen, lower alkyl of 1 to 8 carbon atoms, halogen selected from F, Cl, Br and I, alkoxy containing 1 to 3 carbon atoms, nitro, hydroxy, trifluoromethyl, and thioalkoxy containing 1 to 3 carbon atoms, and x is an integer from 1 to 3, with the proviso that R is the same or different when x is 2 or 3, R.sup.1 and R.sup.2 may be the same or different from each other and are independently selected from the group consisting of hydrogen, lower alkyl of 1 to 8 carbon atoms, aryl, arylalkyl, cyclic propyl and 5 to 7-membered aliphatic cyclic compounds, and R.sup.1 and R.sup.

Abstract: The present invention relates to O-carbamoyl-(D)-phenylalaninol compound represented by the following structural formula V and pharmaceutically acceptable salts thereof to treat diseases of the central nervous system: ##STR1## wherein R.sup.1 and R.sup.2 may be the same with or different from each other and are independently selected from the group consisting of hydrogen, lower alkyl containing 1 to 8 carbon atoms, and 5 to 7-membered aliphatic cyclic compounds which may comprise not more than two nitrogen or oxygen atoms directly unconnected, the total number of carbon atom of R.sup.1 and R.sup.2 ranging from 0 to 16.

Abstract: The thin film heat treatment apparatus for heating the wafers or foil sheets provides a conductively heated table disposed within a vacuum chamber, a heat radiation preventing device that is installed adjacent to the conductively heated table and forms a space with the top of the heater table by surrounding the foil sheet or wafer placed on the top of the heater table.